BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21505976)

  • 21. Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines.
    Lorenzi PL; Llamas J; Gunsior M; Ozbun L; Reinhold WC; Varma S; Ji H; Kim H; Hutchinson AA; Kohn EC; Goldsmith PK; Birrer MJ; Weinstein JN
    Mol Cancer Ther; 2008 Oct; 7(10):3123-8. PubMed ID: 18852115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL.
    Watanabe A; Miyake K; Nordlund J; Syvänen AC; van der Weyden L; Honda H; Yamasaki N; Nagamachi A; Inaba T; Ikawa T; Urayama KY; Kiyokawa N; Ohara A; Kimura S; Kubota Y; Takita J; Goto H; Sakaguchi K; Minegishi M; Iwamoto S; Shinohara T; Kagami K; Abe M; Akahane K; Goi K; Sugita K; Inukai T
    Blood; 2020 Nov; 136(20):2319-2333. PubMed ID: 32573712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of asparagine synthetase on nutrient metabolism in pancreatic disease.
    Tsai CY; Kilberg MS; Husain SZ
    Pancreatology; 2020 Sep; 20(6):1029-1034. PubMed ID: 32800652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase.
    Gwinn DM; Lee AG; Briones-Martin-Del-Campo M; Conn CS; Simpson DR; Scott AI; Le A; Cowan TM; Ruggero D; Sweet-Cordero EA
    Cancer Cell; 2018 Jan; 33(1):91-107.e6. PubMed ID: 29316436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression levels of ASNS in mesenchymal stromal cells in childhood acute lymphoblastic leukemia.
    Dimitriou H; Choulaki C; Perdikogianni C; Stiakaki E; Kalmanti M
    Int J Hematol; 2014 Mar; 99(3):305-10. PubMed ID: 24474640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical characterization of U937 cells resistant to L-asparaginase: the role of asparagine synthetase.
    Kiriyama Y; Kubota M; Takimoto T; Kitoh T; Tanizawa A; Akiyama Y; Mikawa H
    Leukemia; 1989 Apr; 3(4):294-7. PubMed ID: 2564453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic Cytotoxic Effect of L-Asparaginase Combined with Decitabine as a Demethylating Agent in Pediatric T-ALL, with Specific Epigenetic Signature.
    Serravalle S; Bertuccio SN; Astolfi A; Melchionda F; Pession A
    Biomed Res Int; 2016; 2016():1985750. PubMed ID: 28003999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amino acid control of asparagine synthetase: relation to asparaginase resistance in human leukemia cells.
    Hutson RG; Kitoh T; Moraga Amador DA; Cosic S; Schuster SM; Kilberg MS
    Am J Physiol; 1997 May; 272(5 Pt 1):C1691-9. PubMed ID: 9176161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Declined asparagine synthetase mRNA expression and enhanced sensitivity to asparaginase in HL-60 cells committed to monocytic differentiation.
    Hashimoto K; Suzuki F; Sakagami H
    Anticancer Res; 2009 Apr; 29(4):1303-8. PubMed ID: 19414379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL.
    Touzart A; Lengliné E; Latiri M; Belhocine M; Smith C; Thomas X; Spicuglia S; Puthier D; Pflumio F; Leguay T; Graux C; Chalandon Y; Huguet F; Leprêtre S; Ifrah N; Dombret H; Macintyre E; Hunault M; Boissel N; Asnafi V
    Clin Cancer Res; 2019 Apr; 25(8):2483-2493. PubMed ID: 30659025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticancer Properties of N,N-dibenzylasparagine as an Asparagine (Asp) analog, Using Colon Cancer Caco-2 Cell Line.
    Mohamed EA; Bassiouny K; Alshambky AA; Khalil H
    Asian Pac J Cancer Prev; 2022 Jul; 23(7):2531-2540. PubMed ID: 35901362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asparagine synthetase: Function, structure, and role in disease.
    Lomelino CL; Andring JT; McKenna R; Kilberg MS
    J Biol Chem; 2017 Dec; 292(49):19952-19958. PubMed ID: 29084849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoter demethylation of the asparagine synthetase gene is required for ATF4-dependent adaptation to asparagine depletion.
    Jiang J; Srivastava S; Seim G; Pavlova NN; King B; Zou L; Zhang C; Zhong M; Feng H; Kapur R; Wek RC; Fan J; Zhang J
    J Biol Chem; 2019 Dec; 294(49):18674-18684. PubMed ID: 31659118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bisabosqual A: A novel asparagine synthetase inhibitor suppressing the proliferation and migration of human non-small cell lung cancer A549 cells.
    Pan Y; Suzuki T; Sakai K; Hirano Y; Ikeda H; Hattori A; Dohmae N; Nishio K; Kakeya H
    Eur J Pharmacol; 2023 Dec; 960():176156. PubMed ID: 38059445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asparagine synthetase chemotherapy.
    Richards NG; Kilberg MS
    Annu Rev Biochem; 2006; 75():629-54. PubMed ID: 16756505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asparagine synthetase: regulation by cell stress and involvement in tumor biology.
    Balasubramanian MN; Butterworth EA; Kilberg MS
    Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E789-99. PubMed ID: 23403946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-asparaginase induces in AML U937 cells apoptosis via an AIF-mediated mechanism.
    He Y; Li B; Zhang H; Luo C; Shen S; Tang J; Chen J; Gu L
    Front Biosci (Landmark Ed); 2014 Jan; 19(3):515-27. PubMed ID: 24389199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asparagine synthetase expression and its potential prognostic value in patients with NK/T cell lymphoma.
    Li Y; Zhang X; Hu T; Han L; Li R; Wen J; Zhang M
    Oncol Rep; 2014 Aug; 32(2):853-9. PubMed ID: 24913732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asparagine synthetase expression is associated with the sensitivity to asparaginase in extranodal natural killer/T-cell lymphoma in vivo and in vitro.
    Liu WJ; Wang H; Peng XW; Wang WD; Liu NW; Wang Y; Lu Y
    Onco Targets Ther; 2018; 11():6605-6615. PubMed ID: 30349294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-asparaginase anti-tumor activity in pancreatic cancer is dependent on its glutaminase activity and resistance is mediated by glutamine synthetase.
    Blachier J; Cleret A; Guerin N; Gil C; Fanjat JM; Tavernier F; Vidault L; Gallix F; Rama N; Rossignol R; Piedrahita D; Andrivon A; Châlons-Cottavoz M; Aguera K; Gay F; Horand F; Laperrousaz B
    Exp Cell Res; 2023 May; 426(2):113568. PubMed ID: 36967104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.